Literature DB >> 8679458

An analysis of surveillance for stage I combined teratoma--seminoma of the testis.

R Thomas1, D Dearnaley, J Nicholls, A Norman, S Sampson, A Horwich.   

Abstract

We analysed 973 patients with stage I testicular tumours presenting between 1983 and 1994. The median ages at presentation for non-seminomatous germ cell tumour (teratoma) were 27 years, seminoma 36 years and combined tumour 33 years. These differences were statistically significant (Mann-Whitney P < 0.05), suggesting that combined tumours may have a separate natural history. We, therefore, analysed all stage I patients managed with surveillance (530 in total) post orchidectomy. The actuarial 5 year relapse-free survival and anatomical patterns of relapse were identical for non-seminomatous germ cell tumour (NSGCT) and combined tumour and both were statistically distinct from seminoma (P = 0.01, log-rank test, chi-square test P = 0.001). The association of seminoma within a histologically confirmed NSGCT has no influence on the clinical outcome.

Entities:  

Mesh:

Year:  1996        PMID: 8679458      PMCID: PMC2074607          DOI: 10.1038/bjc.1996.315

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  14 in total

1.  Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.

Authors:  S D Williams; D M Stablein; L H Einhorn; F M Muggia; R B Weiss; J P Donohue; D F Paulson; K W Brunner; E M Jacobs; J T Spaulding
Journal:  N Engl J Med       Date:  1987-12-03       Impact factor: 91.245

2.  Proceedings: Distribution of retroperitoneal lymph node metastases in testicular germinal tumors.

Authors:  B Ray; S I Hajdu; W F Whitmore
Journal:  Cancer       Date:  1974-02       Impact factor: 6.860

3.  Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone.

Authors:  L S Freedman; M C Parkinson; W G Jones; R T Oliver; M J Peckham; G Read; E S Newlands; C J Williams
Journal:  Lancet       Date:  1987-08-08       Impact factor: 79.321

4.  Mortality and cancer incidence following radiotherapy for seminoma of the testis.

Authors:  A Horwich; J Bell
Journal:  Radiother Oncol       Date:  1994-03       Impact factor: 6.280

5.  Radiotherapy for stage I seminoma testis: results of treatment and complications.

Authors:  C Hamilton; A Horwich; D Easton; M J Peckham
Journal:  Radiother Oncol       Date:  1986-06       Impact factor: 6.280

6.  Gastrointestinal morbidity of adjuvant radiotherapy in stage I malignant teratoma of the testis.

Authors:  C R Hamilton; A Horwich; J M Bliss; M J Peckham
Journal:  Radiother Oncol       Date:  1987-10       Impact factor: 6.280

7.  Treatment decision for stage I non-seminomatous germ cell tumours based on the risk factor "vascular invasion".

Authors:  W Hoeltl; J Pont; D Kosak; N Honetz; M Marberger
Journal:  Br J Urol       Date:  1992-01

8.  Orchidectomy alone for stage I seminoma of the testis.

Authors:  G M Duchesne; A Horwich; D P Dearnaley; J Nicholls; G Jay; M J Peckham; W F Hendry
Journal:  Cancer       Date:  1990-03-01       Impact factor: 6.860

9.  Surveillance following orchidectomy for stage I testicular seminoma.

Authors:  A Horwich; N Alsanjari; R A'Hern; J Nicholls; D P Dearnaley; C Fisher
Journal:  Br J Cancer       Date:  1992-05       Impact factor: 7.640

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  1 in total

1.  A Review in Management of Testicular Cancer: Single Center Review.

Authors:  Ammar Hameed; Bob White; Frank Chinegwundoh; Ali Thwaini; Ajay Pahuja
Journal:  World J Oncol       Date:  2011-06-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.